Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Malaria Journal|October 7, 2018
A randomized trial of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in MaliSouleymane Dama, Hamidou Niangaly, Moussa Djimde, et al.Scientific Reports|July 6, 2026
Safety, tolerability and pharmacokinetic properties of intranasal artesunate in a first in human phase 1 trialKarim Traore, Anne-Lise Bienvenu, Drissa Coulibaly, et al.Le Mali Medical|March 22, 2024
[Epidemiological and etiological profile of vulvovaginal candidiasis in women in consultation in the gynecology-obstetrics department, CHU Gabriel Toure, Bamako - Mali]Safiatou Niare Doumbo, Niawalou Jacob Dara, Amadou Bamadio, et al.Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in MaliIssaka Sagara, John Woodford, Alassane Dicko, et al.The Journal of Infectious Diseases|October 6, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Seroassay Performance and Optimization in a Population With High Background Reactivity in MaliJohn Woodford, Issaka Sagara, Alassane Dicko, et al.Medrxiv : the Preprint Server for Health Sciences|May 5, 2021
Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort studyIssaka Sagara, John Woodford, Mamady Kone, et al.Frontiers in Epidemiology|March 8, 2024
Tracking SARS-CoV-2 seropositivity in rural communities using blood-fed mosquitoes: a proof-of-concept studyBenjamin J Krajacich, Djibril Samaké, Adama Dao, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2021
Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Limited Clinical Disease in 3 Malian Communities: A Prospective Cohort StudyIssaka Sagara, John Woodford, Mamady Kone, et al.The Lancet. Infectious Diseases|December 19, 2025
Efficacy of ProC6C-AlOH/Matrix-M against Plasmodium falciparum infection and mosquito transmission: a phase 2, randomised, controlled human malaria infection studyMamady Kone, Jordan Plieskatt, Moussa Thienta, et al.Malariaworld Journal|July 15, 2026
Serological evidence of high exposure to <i>Plasmodium falciparum</i> gameto-cytes in dry-Season in Kenieroba, MaliAmatigue Zeguime, Bakary Dao, Drissa Dembele, et al.Pageof 2